Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy (Q34500573)

2 August 2017

1 reference

title

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy (English)

1 reference

2 August 2017

1 reference

O'Brien JJ

1

1 reference

2 August 2017

Campoli-Richards DM

series ordinal

2

1 reference

2 August 2017

publication date

1 March 1989

1 reference

2 August 2017

1 reference

2 August 2017

volume

37

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

233-309

1 reference

Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial

2 August 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of first-attack genital herpes--acyclovir versus inosine pranobex

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Overview of acyclovir pharmacokinetic disposition in adults and children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/2653790

1 reference

12 December 2020

Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and l-lysine on latent ganglionic herpes simplex virus in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effects of acyclovir therapy during simultaneous reactivation of latent HSV-1 in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparative activities of combinations of acyclovir, vidarabine or its 5'-monophosphate, and cloned human interferons against herpes simplex virus type 2 in human and mouse fibroblast cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir for herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of disseminated varicella in childhood malignant neoplasms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir therapy for chickenpox in children with hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of low dose acyclovir (5 mg/kg) on virus shedding, interferon and humoral immunity in herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Major Depression with Psychotic Features Associated with Acyclovir Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir prophylaxis of herpes-simplex-virus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The spectrum of antiviral activities of acyclovir in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Limited value of acyclovir in the treatment of uncomplicated herpes zoster: a placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Regression of oral hairy leukoplakia after orally administered acyclovir therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir for genital herpes--cautious optimism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A case of herpes zoster associated encephalitis with rapid response to acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The clinical pharmacology of acyclovir and its prodrugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir kinetics after intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Intravenous Acyclovir for the Treatment of Primary Genital Herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Failure of topical acyclovir in ointment to penetrate human skin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Hepatitis due to herpes simplex virus in a nonpregnant patient: treatment with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Combination therapy of recombinant human alpha 2 interferon and acyclovir in the treatment of herpes simplex keratitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes encephalitis during pregnancy: failure of acyclovir and adenine arabinoside to prevent neonatal herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylactic and therapeutic treatment with acyclovir of genital herpes in the guinea pig.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Varicella pneumonia during pregnancy. Treatment of two cases with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Recurrences after first episodes of genital herpes in patients treated with topical acyclovir cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir (Zovirax) in herpetic disciform keratitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes simplex infections in atopic eczema

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of twelve unexplained infertile couples

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

[Acyclovir and trifluorothymidine in herpetic kerato-uveitis. A comparative clinical study. Indications for corticoid therapy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of varicella-zoster virus infection in the compromised host

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical acyclovir in the treatment of recurrent herpes simplex virus infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic Efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Metabolic fate of radioactive acyclovir in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Viral origin of hairy leukoplakia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of cytomegalovirus pneumonia with high-dose acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclic Antimetabolite Therapy of Experimental Herpes Simplex Keratitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylactic oral acyclovir in recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical acyclovir treatment of herpes zoster in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

[Acyclovir in mycosis fungoides and lymphomatoid papulosis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylactic oral acyclovir after renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of eczema herpeticum with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir for immunocompromised patients with herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Nausea and vomiting possibly associated with intravenous acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Multiple dose pharmacokinetics of intravenous acyclovir in patients on continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Species differences in the disposition of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Ganglionic permissivity to HSV-1 replication and acyclovir-induced latency: an in vitro model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Amino (hydroxyethoxymethyl) purine: a new well-absorbed prodrug of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effects of acyclovir on herpes virus infection and susceptibility of isolated virus to acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in herpetic keratitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylaxis: a strategy to minimise antiviral resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Combination Therapy for Dendritic Keratitis With Acyclovir and -Interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pharmacokinetics of acyclovir suspension in infants and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pharmacokinetics of oral acyclovir (Zovirax) in the eye.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Inhibition of human cytomegalovirus by combined acyclovir and vidarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and neurologic manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Intravenous Lymphoblastoid Interferon and Acyclovir for Treatment of Cytomegaloviral Pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Genital herpes -- the disease and its treatment including intravenous acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The role of oral acyclovir in the management of genital herpes simplex

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of herpetic whitlow in pregnancy with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Properties of herpesvirus-specific thymidine kinase, DNA polymerase and DNase and their implication in the development of specific antiherpes agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Combined effects of acycloguanosine and humoral antibodies in experimental encephalitis due to Herpesvirus hominis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Cutaneous adverse reactions to acyclovir: case reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Suppression of recurrent genital herpes with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A case of herpes zoster associated encephalitis treated with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and varicella pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in the management of herpes simplex ocular infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Virus resistance in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculat

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of Combined Acyclovir and Vidarabine on Infection with Herpes Simplex Virus in Vitro and in Vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of herpes labialis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Update on acyclovir: oral therapy for herpesvirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Psychiatric side-effects of acyclovir in patients with chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of erythema multiforme secondary to herpes simplex by prophylactic topical acyclovir.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Intravenous acyclovir and neurologic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir: An update of the clinical applications of this antiherpes agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of oral acyclovir treatment of acute herpes zoster.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

In vitro susceptibility of varicella-zoster virus to acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical acyclovir in the management of recurrent herpes labialis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Identification of small DNA fragments synthesized in herpes simplex virus-infected cells in the presence of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir kinetics in end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Viral resistance, clinical experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

[Treatment of congenital varicella with acyclovir]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Intravenous acyclovir in acute herpes zoster infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of herpesvirus infections in the immunocompromised host.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Vesicular eruption. A local complication of concentrated acyclovir infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Disseminated herpes simplex infection in an immunocompromised pregnancy: treatment with intravenous acyclovir.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of herpes simplex keratitis: comparison of acyclovir and vidarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Design of therapeutic studies in herpes simplex encephalitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Chronic herpetic infection in an immunocompromised patient: report of a case

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A randomised controlled study of intravenous acyclovir (Zovirax®) against placebo in adults with chickenpox

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Neonatal acyclovir pharmacokinetics in patients with herpes virus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in accelerated phase of Chediak-Higashi syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Failure of acyclovir cream in treatment of recurrent herpes labialis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Recurrent varicella-zoster infection after acyclovir therapy in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Varicella zoster virus is a cause of the acute retinal necrosis syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

In Vitro Sensitivity to Acyclovir in Genital Herpes Simplex Viruses from Acyclovir-Treated Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Abatement of Sézary syndrome lesions following treatment with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Viral sensitivity following the introduction of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Lymphomatoid papulosis: remission following intravenously administered acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of disseminated herpes simplex virus in pregnancy with parenteral acyclovir. A case report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in cytomegalovirus infection 3 1/2 years after renal transplantation. An unusual case and dramatic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of herpes simplex encephalitis: experience in a district hospital.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effectiveness of intravenous acyclovir in immunocompetent patient with herpes zoster encephalitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Synergistic antiviral effects of acyclovir and vidarabine on herpes simplex infection in newborn mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir-induced renal failure. Clinical course and histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

[Herpetic stomatitis-gingivitis in children: controlled trial of acyclovir versus placebo]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir for the prevention of herpes-associated erythema multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of recurrent genital herpes simplex infections with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes zoster ocular infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Erythema multiforme due to herpes simplex: treatment with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Different in vitro effects of dual combinations of anti-herpes simplex virus compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Varicella-Zoster virus does not become more resistant to acyclovir during therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Clinical pharmacokinetics of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in endoscopically presumed viral esophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Psychiatric side-effects with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in human breast milk

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Post-herpetic erythema multiforme prevented with prophylactic oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Diffuse herpes simplex virus colitis in a kidney transplant recipient successfully treated with acyclovir.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes simplex encephalitis in a patient with lymphoma. Relapse following acyclovir therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Reversible neurotoxicity due to oral acyclovir in a patient with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Relapse of herpes simplex encephalitis after conventional acyclovir therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Neurologic Symptoms Associated with Parenteral Acyclovir Treatment After Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in acute herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Vitrectomy and intravitreal antiviral drug therapy in acute retinal necrosis syndrome. Report of two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Transplacental passage of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: alteration of mortality and pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Clinical and laboratory experience with acyclovir-resistant herpes viruses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Drugs five years later: acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir for recurrent erythema multiforme caused by herpes simplex

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A review of acyclovir treatment of ocular herpes zoster and skin infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The use of in-vitro sensitivity testing to predict clinical response of recurrent herpes simplex to suppressive oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir prophylaxis for herpes simplex virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Clinical resistance to acyclovir of herpes simplex virus infections in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

A Trial of Topical Acyclovir in Genital Herpes Simplex Virus Infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral Acyclovir for Treatment of First-Episode Herpes Simplex Virus Proctitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylactic topical acyclovir for frequent recurrent herpes simplex infection with and without erythema multiforme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Infectious complications in heart-lung transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Systemic acyclovir in pregnancy: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir (Zovirax) ophthalmic ointment: a review of clinical tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment with acyclovir of genital herpes simplex virus infection complicated by eczema herpeticum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Herpes Simplex Acyclovir-Resistant Mutant in Experimental Keratouveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment in a case of facial paralysis caused by herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Resistance of Herpes Simplex Virus to Antiviral Agents Is it Clinically Important?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Allopurinol as an inhibitor of the in vivo formation of acyclovir from desciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir therapy for acute herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Topical acyclovir in the treatment of initial genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir administered perorally in immunocompromised children with varicella-zoster infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Antiviral treatment of a serious herpes simplex infection: encephalitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Disseminated herpes simplex virus infection in pregnancy. Successful treatment with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Treatment of eczema herpeticum with systemic acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Long-term oral acyclovir treatment prevents recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The disposition of 6-deoxyacyclovir, a xanthine oxidase-activated prodrug of acyclovir, in the isolated perfused rat liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir versus trifluorothymidine in the therapy of stromal herpes keratitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Susceptibility of HSV strains from patients with genital herpes treated with various formulations of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Synergistic inhibitory effect of acyclovir and human native beta-interferon on the growth of herpes simplex virus type 2 in human embryo fibroblast cell cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and suppression of frequently recurring herpetic whitlow

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir prevents herpes simplex virus-associated erythema multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effects of acyclovir combined with other antiviral agents on human cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Vidarabine versus acyclovir therapy in herpes simplex encephalitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effectiveness of oral acyclovir prophylaxis in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

The intraocular penetration of acyclovir after subconjunctival administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Failure of acyclovir cream in treatment of recurrent herpes labialis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Rapid response to acyclovir in herpes zoster-associated encephalitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Phosphorylation of acyclovir in vitro in activated Burkitt somatic cell hybrids

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Adverse reactions to acyclovir: topical, oral, and intravenous

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Identification of an Epstein-Barr virus-coded thymidine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Disseminated herpes simplex infection complicating Darier's disease: successful treatment with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in herpes zoster oticus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in the treatment of herpetic stromal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir resistance in a patient with chronic mucocutaneous herpes simplex infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and disseminated varicella zoster and encephalitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir prevents dissemination of varicella in immunocompromised children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Sensitivity of HSV strains isolated before and after treatment with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Intracellular Pools of Thymidine Reduce the Antiviral Action of Acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir treatment of experimental genital herpes simplex virus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in the management of dendritic herpetic corneal ulceration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

In vitro and in vivo responses of cytomegalovirus to acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Episodic twice-daily treatment for recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Combined antiviral effects of acyclovir or bromovinyldeoxyuridine and human immunoglobulin in herpes simplex virus-infected mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Therapeutic challenges of neonatal herpes simplex virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and the treatment of herpetic whitlow

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir therapy for eczema herpeticum in infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and Epstein--Barr virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Combination Therapy for Dendritic Keratitis with Human Leukocyte Interferon and Acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Response of immunocompromised patients with acute herpes zoster to intravenous acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Enhanced efficacy of nucleoside analogs and recombinant alpha interferon in weanling mice lethally infected with herpes simplex virus type 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Suppression of HSV-1 infection in trigeminal ganglion cells. An in vitro model of latency

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Cooperative effects between two acyclovir resistance loci in herpes simplex virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Prophylaxis against herpes labialis with acyclovir cream--a placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

[Comparison of the effectiveness of acyclovir and vidarabine in superficial herpes keratitis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Trigeminal Ganglion Infection by Thymidine Kinase-Negative Mutants of Herpes Simplex Virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir in Oral and Ganglionic Herpes Simplex Virus Infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Acyclovir and idoxiuridine treatment of herpes simplex keratitis--a double blind clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Therapy of herpes zoster with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Influence of Cells and Virus Multiplicity on the Inhibition of Herpesviruses with Acycloguanosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Oral and intravenous acyclovir are equally effective in herpes zoster

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

High-dose intravenous acyclovir in the treatment of zoster: A double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

Successful management of acute retinal necrosis with intravenous acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/2653790

12 December 2020

10.2165/00003495-198937030-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1034371652

0 references

1 reference